Results 31 to 40 of about 849 (67)

Targeting Glioma Stem Cells: Therapeutic Opportunities and Challenges. [PDF]

Cells
Mahdi A, Aittaleb M, Tissir F.
europepmc   +1 more source

Berberine-based strategies: novel delivery systems bring out new potential for wound healing. [PDF]

Chin Med
Yin J, Qin S, Chen J, Wong N, Peng C, Li D.   +5 more
europepmc   +1 more source

Infigratinib, a selective FGFR1-3 tyrosine kinase inhibitor, alters dentoalveolar development at high doses. [PDF]

Dev Dyn, 2023
Michel ZD, Aitken SF, Glover OD, Alejandro LO, Randazzo D, Dambkowski C, Martin D, Collins MT, Somerman MJ, Chu EY.   +9 more
europepmc   +1 more source

Lymphadenectomy in upper tract urothelial carcinoma: Clinical insights and controversies (Review). [PDF]

Oncol Rep
Lv D, Huang Y, Li H, Fu S, Gong C, Yang C, Wang J, Wang H, Tan Z, Ding M.   +9 more
europepmc   +1 more source

Phosphoproteomic Changes Induced by Cell-Derived Matrix and Their Effect on Tumor Cell Migration and Cytoskeleton Remodeling. [PDF]

ACS Biomater Sci Eng, 2023
Shimpi AA, Williams ED, Ling L, Tamir T, White FM, Fischbach C.   +5 more
europepmc   +1 more source

Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer. [PDF]

Invest New Drugs
Owen DH, Wu R, Wei L, Dikov M, Suman S, Su PL, Amann J, Guan S, Spakowicz D, Schweitzer C, Pilcher C, Smith MB, Ferguson S, Palomino JC, Pérez SF, Bertino EM, Shields PG, He K, Presley CJ, Otterson GA, Carson WE, Carbone DP.   +21 more
europepmc   +1 more source

Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitors. [PDF]

BMC Chem
Abdel-Mohsen HT, Ibrahim MA, Nageeb AM, El Kerdawy AM.   +3 more
europepmc   +1 more source

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential. [PDF]

J Exp Clin Cancer Res, 2023
Alors-Pérez E, Pedraza-Arevalo S, Blázquez-Encinas R, Moreno-Montilla MT, García-Vioque V, Berbel I, Luque RM, Sainz B, Ibáñez-Costa A, Castaño JP.   +9 more
europepmc   +1 more source

Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma. [PDF]

J Urol
Matin SF, Adibi M, Shah AY, Alhalabi O, Corn P, Guo C, Amirtharaj R, Xiao L, Lange S, Duose DY, Wang S, Pal S, Campbell MT.   +12 more
europepmc   +1 more source

Advancements in lung regeneration: from bench to bedside. [PDF]

J Transl Med
Khayatan D, Barzegar PEF, Fatima A, Sattar T, Zahid A, Batool SA, Jabbar M, Mureed M, Haider F, Butt AJ, Hanif S, Seifalian A, Tebyaniyan H.   +12 more
europepmc   +1 more source